A quick fix would stop drug firms bending the truth
It’s not just about Prozac. Our failure to properly regulate testing in the pharmaceutical industry has devastating costs Ben Goldacre
The Guardian,
Wednesday February 27 2008
Yesterday the journal PLoS Medicine published a study which combined the results of 47 trials on some antidepressant drugs, including Prozac, and found only minimal benefits over placebo, except for the most depressed […]
